Leyla Raiani
Feb 16, 2012

Four new drugs will change prostate cancer care

According to a leading Colorado prostate cancer expert, after a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer a chronic illness instead of a terminal disease. The drugs have different and innovative methods of action. The first drug is a bone protective agent, the second is a more effective hormone agent, third is a new form of radiotherapy and the final one is the first drug tested for cancer immunotherapy. David Crawford, MD, investigator at the University of Colorado Cancer Center, notes that these drugs are being approved for use only in patients who have had more established therapies fail and hopes that in coming years science may accelerate the use of these drugs to first-line therapies.

Companies
1
Patents
1
Related Articles
Kristin Wall
Oct 21, 2011
Is the government cutting corners in developing cancer treatments?
Developing drugs to fight cancer, the fourth most prevalent cause of human deaths worldwide, is a mission beyond reproach. That... Read More
Ann Conkle
Feb 10, 2012
Curry spice component may help slow prostate tumor growth
Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer... Read More
Ann Conkle
Feb 15, 2012
New method to treat prostate and pancreatic cancer with lasers
Laser light in combination with certain drugs – known as photodynamic therapy – can destroy cancer tumors. But, this method... Read More